stage ivb lung cancer ajcc v8
Showing 51 - 75 of 81
Lung Carcinoma, Metastatic Malignant Tumor in the Lung, Stage IV Lung Cancer AJCC v8 Trial in Palo Alto (procedure, drug, other)
Active, not recruiting
- Lung Carcinoma
- +4 more
- Near-Infrared Fluorescence Imaging
- +3 more
-
Palo Alto, CaliforniaStanford University, School of Medicine
Jun 21, 2022
Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Portland (Best Practice,
Recruiting
- Lung Non-Small Cell Carcinoma
- +15 more
- Best Practice
- +2 more
-
Portland, Oregon
- +1 more
Jun 8, 2022
Malignant Female Reproductive System Tumor, Stage 0 Lung Cancer AJCC v8, Stage I Lung Cancer AJCC v8 Trial in Duarte
Active, not recruiting
- Malignant Female Reproductive System Neoplasm
- +16 more
- Educational Intervention
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 7, 2022
Advanced Lung Carcinoma, Metastatic Malignant Female Reproductive System Tumor, Stage III Lung Cancer AJCC v8 Trial in Duarte
Active, not recruiting
- Advanced Lung Carcinoma
- +8 more
- Educational Intervention
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 3, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Solid Tumor Trial in
Suspended
- Anatomic Stage IV Breast Cancer AJCC v8
- +8 more
- Atezolizumab
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
May 23, 2022
Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8 Trial (Nivolumab,
Withdrawn
- Lung Non-Small Cell Carcinoma
- +12 more
- Nivolumab
- Sapanisertib
- (no location specified)
May 24, 2022
Lung Non-Small Cell Carcinoma, Positive Surgical Margin, Resected Mass Trial in Buffalo (Quality-of-Life Assessment,
Recruiting
- Lung Non-Small Cell Carcinoma
- +9 more
- Quality-of-Life Assessment
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
May 2, 2022
Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in
Recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +4 more
- Atezolizumab
- Tretinoin
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Apr 27, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Lung Carcinoma Trial in Columbus (Health
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +7 more
- Health Education
- Questionnaire Administration
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Apr 18, 2022
Advanced Lung Carcinoma, Metastatic Lung Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Columbus (Behavioral, Psychological or
Recruiting
- Advanced Lung Carcinoma
- +4 more
- Behavioral, Psychological or Informational Intervention
- +4 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Apr 18, 2022
Metastatic Lung Adenocarcinoma, Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Adenocarcinoma Trial in United States
Recruiting
- Metastatic Lung Adenocarcinoma
- +6 more
- Pembrolizumab
- +5 more
-
Anchorage, Alaska
- +466 more
Apr 18, 2022
Metastatic Lung Small Cell Carcinoma, Metastatic Malignant Tumor in the Brain, Recurrent Lung Small Cell Carcinoma Trial in
Recruiting
- Metastatic Lung Small Cell Carcinoma
- +5 more
- Memantine Hydrochloride
- +3 more
-
Phoenix, Arizona
- +83 more
Apr 8, 2022
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8
Recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +129 more
- Cyclophosphamide
- +3 more
-
Jacksonville, FloridaMayo Clinic in Florida
Apr 8, 2022
Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma
Not yet recruiting
- Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8
- +45 more
- Internet-Based Intervention
- +2 more
-
Manhasset, New York
- +3 more
Mar 30, 2022
Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in
Recruiting
- Advanced Differentiated Thyroid Gland Carcinoma
- +102 more
- Cabozantinib S-malate
- Nivolumab
-
Chicago, Illinois
- +2 more
Apr 5, 2022
Metastatic Lung Small Cell Carcinoma, Metastatic Malignant Solid Tumor, Metastatic Neuroendocrine Carcinoma Trial in United
Recruiting
- Metastatic Lung Small Cell Carcinoma
- +16 more
- Elimusertib
- +2 more
-
Phoenix, Arizona
- +10 more
Mar 25, 2022
Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Atlanta
Recruiting
- Advanced Lung Non-Small Cell Carcinoma
- +4 more
- Flt3/MerTK Inhibitor MRX-2843
- Osimertinib
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Mar 8, 2022
Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Stage III
Terminated
- Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma
- +9 more
- Bintrafusp Alfa
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Mar 4, 2022
Lung Carcinoid Tumor, Lung Non-Small Cell Carcinoma, Metastatic Lung Carcinoma Trial in Houston (Cone-Beam Computed Tomography,
Completed
- Lung Carcinoid Tumor
- +5 more
- Cone-Beam Computed Tomography
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Feb 14, 2022
Advanced Malignant Solid Tumor, Extensive Stage Lung Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 Trial in Los Angeles
Recruiting
- Advanced Malignant Solid Neoplasm
- +8 more
- Atezolizumab
- +4 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Feb 7, 2022
Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 Trial (Fluorine
Withdrawn
- Advanced Lung Non-Small Cell Carcinoma
- +8 more
- Fluorine F 18 Ara-G
- (no location specified)
Jan 24, 2022
Advanced Lung Carcinoma, Advanced Malignant Solid Tumor, Malignant Adrenal Gland Tumor Trial in Houston (Anti-CTLA4 Monoclonal
Recruiting
- Advanced Lung Carcinoma
- +16 more
- Anti-CTLA4 Monoclonal Antibody BMS-986218
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jan 20, 2022
Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in
Recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +4 more
- Pembrolizumab
- Ramucirumab
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Nov 22, 2021
Advanced Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8 Trial in Scottsdale,
Active, not recruiting
- Advanced Lung Non-Small Cell Carcinoma
- +7 more
- Bintrafusp Alfa
- Docetaxel
-
Scottsdale, Arizona
- +2 more
Nov 3, 2021
Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8 Trial (Carboplatin, Durvalumab,
Withdrawn
- Lung Non-Small Cell Carcinoma
- +4 more
- Carboplatin
- +3 more
- (no location specified)
Oct 26, 2021